Pembrolizumab monotherapy for the adjuvant treatment of renal cell carcinoma post-nephrectomy: Randomized, double-blind, Phase III KEYNOTE-564 study

Affiliation auteurs!!!! Error affiliation !!!!
TitrePembrolizumab monotherapy for the adjuvant treatment of renal cell carcinoma post-nephrectomy: Randomized, double-blind, Phase III KEYNOTE-564 study
Type de publicationJournal Article
Year of Publication2019
AuteursChoueiri TK, Quinn DI, Zhang T, Gurney H, Doshi GK, Cobb PWayne, Parnis F, Lee J-L, Park SHoon, Semenov A, Thiery-Vuillemin A, Sawrycki P, Tomczak P, Alekseev B, Izmailov A, Chang WYen-Hwa, Wan SM, Poehlein CHeinrich, Willemann-Rogerio J, Powles T
JournalCANCER RESEARCH
Volume79
Date PublishedJUL
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.AM2019-CT162